erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
. we have let patients down, admits senior northern ireland civil servant
.
"but only when we discovered wet baby car seats in the first summer, we became really excited about the effect of the treatment," she said.
.
.